J. Provençal

790 total citations
10 papers, 366 citations indexed

About

J. Provençal is a scholar working on Oncology, Physiology and Reproductive Medicine. According to data from OpenAlex, J. Provençal has authored 10 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 2 papers in Physiology and 2 papers in Reproductive Medicine. Recurrent topics in J. Provençal's work include Cancer Treatment and Pharmacology (4 papers), Cancer survivorship and care (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). J. Provençal is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Cancer survivorship and care (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). J. Provençal collaborates with scholars based in France, Switzerland and Canada. J. Provençal's co-authors include B. Weber, Éric Pujade-Lauraine, Gilles Freyer, Sandrine Touzet, J.-F. Geay, G. Ganem, J.P. Jacquin, N. Tubiana-Mathieu, O. Gisserot and J Crétin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

J. Provençal

9 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Provençal France 5 169 148 106 86 77 10 366
J.-F. Geay France 6 169 1.0× 176 1.2× 106 1.0× 200 2.3× 84 1.1× 15 479
J.P. Jacquin France 8 211 1.2× 215 1.5× 209 2.0× 62 0.7× 106 1.4× 12 512
Björn Penninckx United Kingdom 5 146 0.9× 160 1.1× 82 0.8× 27 0.3× 93 1.2× 7 378
Francesco Savinelli France 6 79 0.5× 90 0.6× 103 1.0× 43 0.5× 36 0.5× 13 259
M.J. Tennapel United States 12 76 0.4× 86 0.6× 133 1.3× 9 0.1× 104 1.4× 41 425
Alberto Daniele Italy 7 25 0.1× 122 0.8× 33 0.3× 108 1.3× 16 0.2× 13 276
Capucine Baldini France 10 93 0.6× 184 1.2× 41 0.4× 10 0.1× 96 1.2× 19 336
Chie Akiba United States 5 333 2.0× 223 1.5× 195 1.8× 5 0.1× 131 1.7× 7 597
L. Casanova Peru 7 30 0.2× 193 1.3× 11 0.1× 16 0.2× 48 0.6× 12 314
Elizabeth Won United States 10 59 0.3× 172 1.2× 65 0.6× 7 0.1× 130 1.7× 22 307

Countries citing papers authored by J. Provençal

Since Specialization
Citations

This map shows the geographic impact of J. Provençal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Provençal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Provençal more than expected).

Fields of papers citing papers by J. Provençal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Provençal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Provençal. The network helps show where J. Provençal may publish in the future.

Co-authorship network of co-authors of J. Provençal

This figure shows the co-authorship network connecting the top 25 collaborators of J. Provençal. A scholar is included among the top collaborators of J. Provençal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Provençal. J. Provençal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Brunelle, Cheryl L., Stéphane Bally, J. Provençal, & C. Lecomte. (2016). [Orbital inflammatory pseudotumor secondary to sarcoidosis].. Journal Français d Ophtalmologie. 39(7). e179–81. 1 indexed citations
2.
Deschamps, M. & J. Provençal. (2012). Une névrite optique toxique induite par le sunitinib. ONCOLOGIE. 14(12). 679–681.
3.
Gross‐Goupil, Marine, A. Fourcade, Emmanuel Blot, et al.. (2012). Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trial. European Journal of Cancer. 48(5). 721–727. 33 indexed citations
4.
5.
Ray-Coquard, Isabelle Laure, J. Provençal, Anne‐Claire Hardy‐Bessard, et al.. (2009). Can adjuvant homeopathy improve the control of post-chemotherapy emesis in breast cancer patients? Results of a randomized placebo-controlled trial. Journal of Clinical Oncology. 27(15_suppl). e20566–e20566. 1 indexed citations
6.
Ray‐Coquard, Isabelle, B. Weber, J Crétin, et al.. (2009). Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group. British Journal of Cancer. 100(4). 601–607. 20 indexed citations
7.
Bachelot, Thomas, Agathe Bajard, Isabelle Ray‐Coquard, et al.. (2009). Superiority of Docetaxel + Capecitabine Compared to Docetaxel + Epirubicin as First-Line Therapy for Metastatic Breast Cancer – Final Results of the ERASME-4 Study.. Cancer Research. 69(24_Supplement). 2099–2099. 2 indexed citations
8.
Bachelot, Thomas, É. Luporsi, Agathe Bajard, et al.. (2008). Randomized trial of first-line docetaxel + capecitabine (XT) versus docetaxel + epirubicin (ET) for metastatic breast cancer (MBC): Efficacy results of ERASME-4/CAPEDOC-EPIDOC. Journal of Clinical Oncology. 26(15_suppl). 1049–1049. 1 indexed citations
9.
10.
Freyer, Gilles, J.-F. Geay, Sandrine Touzet, et al.. (2005). Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Annals of Oncology. 16(11). 1795–1800. 251 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.-F. Geay Breakdown of academic impact, for papers by J.P. Jacquin Breakdown of academic impact, for papers by Björn Penninckx Breakdown of academic impact, for papers by Francesco Savinelli Breakdown of academic impact, for papers by M.J. Tennapel Breakdown of academic impact, for papers by Alberto Daniele Breakdown of academic impact, for papers by Capucine Baldini Breakdown of academic impact, for papers by Chie Akiba Breakdown of academic impact, for papers by L. Casanova Breakdown of academic impact, for papers by Elizabeth Won
Rankless by CCL
2026